ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,517, issued on Aug. 12, was assigned to Spring Works Therapeutics Inc. (Stamford, Conn.).
"Dosage forms of mirdametinib" was invented by Piero L. Ruggiero (Stamford, Conn.), Kristin Patterson (Stamford, Conn.), Mark Hatcher (Stamford, Conn.), Jiping Liu (Stamford, Conn.), Uchenna H. Iloeje (Stamford, Conn.) and Abraham J. Langseth (Stamford, Conn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an oral dosage form, such as a capsule, comprising (a) mirdametinib having a d90 no more than 250 microns, a d50 no more than 50 microns, or both, and (b) one or more pharmaceutically acceptable excipients. These dosage forms ...